CEPI announces support for fourth Nipah virus vaccine
The Coalition for Epidemic Preparedness Innovations (CEPI) and Public Health Vaccines (PHV), LLC, have announced a partnership agreement worth up to $43.6 million to support the development and manufacturing of a Nipah virus vaccine.
In a statement today CEPI said it will fund preclinical studies, clinical studies through phase 2, manufacturing, and an investigational stockpile of the vaccine candidate.